DIASORIN INC

Diasorin Inc. specializes in the manufacturing and supply of in-vitro diagnostic substances and analytical laboratory instrumentation for clinical and military healthcare applications. The company delivers reagents, controls, and standardized test kits used in chemiluminescence and immunoassay platforms, alongside fully integrated analytical analyzers such as the LIAISON XL and LIAISON 66 III systems. Their technical expertise lies in precision diagnostic manufacturing, assay validation, and turnkey laboratory supply solutions that ensure consistent, FDA-cleared performance in high-volume clinical environments. Key differentiators include end-to-end control over reagent chemistry, instrument compatibility, and just-in-time logistics for critical diagnostic materials in regulated settings. The contractor maintains a primary relationship with the Department of Veterans Affairs, supplying diagnostic reagents and laboratory analyzers for VA medical centers nationwide. Additional work supports the Department of Defense with laboratory testing reagents for military healthcare facilities, and the Department of Health and Human Services with diagnostic infrastructure for public health laboratories. These engagements reflect a pattern of sustained, mission-critical supply chain partnerships focused on sustaining diagnostic capacity in federal healthcare networks. Diasorin Inc. operates primarily within NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), positioning itself as a niche provider of clinical diagnostics for government laboratories. Their market focus is on immunoassay-based testing systems, automation-ready analyzers, and companion reagent kits used in infectious disease, endocrine, and autoimmune diagnostics—areas critical to veteran and military health surveillance. The company is structured as a 2L entity with its primary operations based in Stillwater, Minnesota. While no federal certifications are listed, its consistent award history demonstrates proven compliance with federal procurement standards for medical diagnostics and laboratory equipment. Its geographic footprint is centered on supporting federal healthcare infrastructure across the U.S., with no indication of international or commercial market focus.